Clinical trials
Terminated Kidney Failure, Chronic trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
80 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2002 | 1 |
| 2003 | 2 |
| 2004 | 3 |
| 2005 | 7 |
| 2006 | 6 |
| 2007 | 6 |
| 2008 | 2 |
| 2009 | 5 |
| 2010 | 4 |
| 2011 | 1 |
| 2012 | 3 |
| 2013 | 4 |
| 2014 | 6 |
| 2015 | 4 |
| 2016 | 3 |
| 2017 | 2 |
| 2018 | 5 |
| 2019 | 5 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 3 |
| 2023 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 80 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ineos Healthcare Limited | 3 |
| Brigham and Women's Hospital | 2 |
| Cara Therapeutics, Inc. | 2 |
| Fresenius Medical Care North America | 2 |
| Johns Hopkins University | 2 |
| Kaiser Permanente | 2 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 2 |
| University of Arkansas | 2 |
| University of Chicago | 2 |
| University of Nebraska | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Kidney Failure, Chronic | 80 |
| Renal Insufficiency, Chronic | 13 |
| Renal Insufficiency | 8 |
| Kidney Diseases | 6 |
| Acute Kidney Injury | 5 |
| Anemia | 5 |
| Diabetes Mellitus, Type 2 | 3 |
| Hyperphosphatemia | 3 |
| Malnutrition | 3 |
| Arteriovenous Fistula | 2 |
Trials
Showing 1 to 25 of 80. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.